Summary & Overview
HCPCS M1161: Anaphylaxis Due to Tetanus/Diphtheria/Pertussis Vaccine, Pediatric
HCPCS Level II code M1161 documents a history of anaphylaxis due to the tetanus, diphtheria, or pertussis vaccine occurring on or before a patient’s 13th birthday. This code signals a clinically significant vaccine-related severe allergic reaction and is used to flag patients with prior anaphylaxis when considering future immunizations or documenting adverse event history. Nationally, clear capture of vaccine-related anaphylaxis supports patient safety, continuity of care, and appropriate clinical decision-making across immunization programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for M1161, typical sites of service, and the service type. The publication outlines common billing considerations tied to documentation of vaccine-related anaphylaxis and highlights which administrative elements are available or absent in the source input. Benchmarks, payer policy nuances, and related coding guidance are summarized where present; missing inputs are noted as unavailable.
This summary is written for a national audience and is intended to help clinicians, billing staff, and policy analysts understand the purpose of M1161, where it is commonly applied, and what information is included in the source data.
Billing Code Overview
HCPCS Level II code M1161 documents a history of anaphylaxis attributed to the tetanus, diphtheria, or pertussis vaccine occurring any time on or before the patient's 13th birthday. The code captures a vaccine-related severe allergic reaction as part of the patient’s medical record.
Service type: Vaccine-related adverse event documentation / Immunization complication diagnosis
Typical site of service: Outpatient clinics, emergency departments, urgent care centers, and immunization or public health clinics
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 10-year-old child presents to the pediatric clinic with a documented history of severe immediate hypersensitivity (anaphylaxis) that occurred after administration of a tetanus, diphtheria, or pertussis-containing vaccine on or before their 13th birthday. The caregiver brings prior immunization records and an emergency department note confirming anaphylaxis (respiratory distress, hypotension, or angioedema requiring epinephrine). The clinical workflow includes confirmation of the diagnosis, review of vaccine component exposure, allergy/immunology consultation as indicated, documentation of vaccine contraindication in the permanent medical record and Immunization Information System, discussion of alternative vaccine options or deferral, provision of anaphylaxis action plan and medical alert guidance, and communication of contraindication to primary care and school health services. Billing for the patient’s vaccine contraindication is linked to the HCPCS Level II code M1161, used to indicate anaphylaxis to tetanus-, diphtheria-, or pertussis-containing vaccines occurring on or before age 13. Typical sites of service include outpatient pediatric clinics, primary care offices, allergy/immunology clinics, and emergency departments for initial event documentation. The typical patient scenario involves documentation review, clinical evaluation, counseling, and care coordination rather than administration of an immunization at that encounter.
Coding Specifications
- For
M1161, the most clinically relevant modifiers are listed below with typical use.
| Modifier | Description | When to Use |
|---|